South Korea
· Delayed Price · Currency is KRW Precision Biosensor Statistics
Total Valuation
Precision Biosensor has a market cap or net worth of KRW 44.25 billion. The enterprise value is 55.47 billion.
| Market Cap | 44.25B |
| Enterprise Value | 55.47B |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Precision Biosensor has 11.61 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Shares Outstanding | 11.61M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.43% |
| Owned by Institutions (%) | 2.22% |
| Float | 10.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.58 |
| PB Ratio | 1.48 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.15 |
| EV / Sales | 3.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.12 |
Financial Position
The company has a current ratio of 3.01, with a Debt / Equity ratio of 0.57.
| Current Ratio | 3.01 |
| Quick Ratio | 1.35 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.49 |
| Interest Coverage | -4.03 |
Financial Efficiency
Return on equity (ROE) is -21.64% and return on invested capital (ROIC) is -9.33%.
| Return on Equity (ROE) | -21.64% |
| Return on Assets (ROA) | -7.78% |
| Return on Capital (ROIC) | -9.33% |
| Revenue Per Employee | 167.99M |
| Profits Per Employee | -66.73M |
| Employee Count | 102 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 1.30 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.80% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -32.80% |
| 50-Day Moving Average | 3,828.20 |
| 200-Day Moving Average | 4,488.98 |
| Relative Strength Index (RSI) | 52.44 |
| Average Volume (20 Days) | 210,906 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Precision Biosensor had revenue of KRW 17.14 billion and -6.81 billion in losses. Loss per share was -586.66.
| Revenue | 17.14B |
| Gross Profit | 5.15B |
| Operating Income | -7.23B |
| Pretax Income | -7.51B |
| Net Income | -6.81B |
| EBITDA | -3.90B |
| EBIT | -7.23B |
| Loss Per Share | -586.66 |
Balance Sheet
The company has 5.78 billion in cash and 17.00 billion in debt, giving a net cash position of -11.22 billion or -965.78 per share.
| Cash & Cash Equivalents | 5.78B |
| Total Debt | 17.00B |
| Net Cash | -11.22B |
| Net Cash Per Share | -965.78 |
| Equity (Book Value) | 29.94B |
| Book Value Per Share | 2,578.09 |
| Working Capital | 11.70B |
Cash Flow
In the last 12 months, operating cash flow was -2.70 billion and capital expenditures -4.13 billion, giving a free cash flow of -6.83 billion.
| Operating Cash Flow | -2.70B |
| Capital Expenditures | -4.13B |
| Free Cash Flow | -6.83B |
| FCF Per Share | -588.35 |
Margins
Gross margin is 30.03%, with operating and profit margins of -42.18% and -39.72%.
| Gross Margin | 30.03% |
| Operating Margin | -42.18% |
| Pretax Margin | -43.84% |
| Profit Margin | -39.72% |
| EBITDA Margin | -22.78% |
| EBIT Margin | -42.18% |
| FCF Margin | -39.88% |
Dividends & Yields
Precision Biosensor does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | -0.04% |
| Earnings Yield | -15.40% |
| FCF Yield | -15.44% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Precision Biosensor has an Altman Z-Score of 0.66. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.66 |
| Piotroski F-Score | n/a |